| Dr Sangeeta Khanna, MD | |
|
1000 Wall St, Ann Arbor, MI 48105-1912 | |
| (734) 764-4190 | |
| Not Available |
| Full Name | Dr Sangeeta Khanna |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 1000 Wall St, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245445634 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301503651 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
Using a novel surgical approach, it's possible to rebuild the trachea and preserve a patient's voice after removing an invasive throat tumor, according to a new report from Henry Ford Hospital in Detroit.
PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic fibrosis (nmCF) in the American Journal of Respiratory and Critical Care Medicine.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
Astellas Pharma Inc. and Ambit Biosciences Corporation announced today that the results from a completed Phase 2 study with the investigational FLT3 inhibitor, quizartinib (AC220), as an oral monotherapy treatment regimen in patients with relapsed or refractory acute myeloid leukemia (AML) were presented at the 54th Annual Meeting of the American Society of Hematology (ASH).
Dance therapy can be a successful method for reaching children and adolescents with problems. This has been shown in a research project at Karlstad University and the University College of Dance in Stockholm, Sweden.
› Verified 4 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568495299 PECOS PAC ID: 3779496856 Enrollment ID: O20031118000092 |
News Archive
Using a novel surgical approach, it's possible to rebuild the trachea and preserve a patient's voice after removing an invasive throat tumor, according to a new report from Henry Ford Hospital in Detroit.
PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic fibrosis (nmCF) in the American Journal of Respiratory and Critical Care Medicine.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
Astellas Pharma Inc. and Ambit Biosciences Corporation announced today that the results from a completed Phase 2 study with the investigational FLT3 inhibitor, quizartinib (AC220), as an oral monotherapy treatment regimen in patients with relapsed or refractory acute myeloid leukemia (AML) were presented at the 54th Annual Meeting of the American Society of Hematology (ASH).
Dance therapy can be a successful method for reaching children and adolescents with problems. This has been shown in a research project at Karlstad University and the University College of Dance in Stockholm, Sweden.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sangeeta Khanna, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Dr Sangeeta Khanna, MD 1000 Wall St, Ann Arbor, MI 48105-1912 Ph: (734) 764-4190 |
News Archive
Using a novel surgical approach, it's possible to rebuild the trachea and preserve a patient's voice after removing an invasive throat tumor, according to a new report from Henry Ford Hospital in Detroit.
PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic fibrosis (nmCF) in the American Journal of Respiratory and Critical Care Medicine.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
Astellas Pharma Inc. and Ambit Biosciences Corporation announced today that the results from a completed Phase 2 study with the investigational FLT3 inhibitor, quizartinib (AC220), as an oral monotherapy treatment regimen in patients with relapsed or refractory acute myeloid leukemia (AML) were presented at the 54th Annual Meeting of the American Society of Hematology (ASH).
Dance therapy can be a successful method for reaching children and adolescents with problems. This has been shown in a research project at Karlstad University and the University College of Dance in Stockholm, Sweden.
› Verified 4 days ago
Said M Issa, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2900 Golfside Dr, Suite 2, Ann Arbor, MI 48108 Phone: 313-724-2733 Fax: 313-724-2456 | |
Jill Elizabeth Bixler, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall Street, Ann Arbor, MI 48105 Phone: 734-764-4190 | |
Paul P Lee, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall Street, Ann Arbor, MI 48105 Phone: 734-764-4190 | |
Monte Anthony Delmonte, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall St, Ann Arbor, MI 48105 Phone: 734-764-4190 | |
Denise Ann-marie John, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall Street, Ann Arbor, MI 48105 Phone: 734-764-4190 | |
Brittany A Simmons, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall St, Ann Arbor, MI 48105 Phone: 734-764-4190 | |
Alexander Valentine, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1000 Wall St, Ann Arbor, MI 48105 Phone: 734-763-8122 |